Par Pharmaceutical, Inc. et al v. Long Grove Pharmaceuticals, LLC
| Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC |
| Long Grove Pharmaceuticals, LLC |
| 1:2023cv01412 |
| December 8, 2023 |
| US District Court for the District of Delaware |
| Gregory B Williams |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 2, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 12 Pro Hac Vice Fee - Credit Card Payment received for Kerry B. McTigue, W. Blake Coblentz, Aaron S. Lukas, and Keri L. Schaubert. ( re #11 MOTION for Pro Hac Vice Appearance of Attorney Kerry B. McTigue, W. Blake Coblentz, Aaron S. Lukas, and Keri L. Schaubert )( Payment of $ 200, receipt number ADEDC-4329839).(Ekiner, Kaan) |
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Kerry B. McTigue, W. Blake Coblentz, Aaron S. Lukas, and Keri L. Schaubert - filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Ekiner, Kaan) |
| Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Long Grove Pharmaceuticals Holdings, LLC for Long Grove Pharmaceuticals, LLC filed by Long Grove Pharmaceuticals, LLC. (Farnan, Kelly) |
| Filing 9 [SEALED] ANSWER to #1 Complaint, by Long Grove Pharmaceuticals, LLC. (Attachments: #1 Exhibit A-O)(Farnan, Kelly) |
SO ORDERED, re #8 STIPULATION TO EXTEND TIME for Defendant to answer, move or otherwise respond to the Complaint to February 1, 2024 filed by Long Grove Pharmaceuticals, LLC. Signed by Judge Gregory B. Williams on 1/2/24. (ntl)
|
| Filing 8 STIPULATION TO EXTEND TIME for Defendant to answer, move or otherwise respond to the Complaint to February 1, 2024 - filed by Long Grove Pharmaceuticals, LLC. (Farnan, Kelly) |
| Filing 7 SUMMONS Returned Executed by Par Pharmaceutical, Inc., Par Sterile Products, LLC, Endo Par Innovation Company, LLC.Long Grove Pharmaceuticals, LLC served on 12/11/2023, answer due 1/2/2024. (Ekiner, Kaan) |
| Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) |
| Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (jfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Par Pharmaceutical, Inc. for Endo Par Innovation Company, LLC and Par Sterile Products, LLC; Corporate Parent Endo International PLC for Par Pharmaceutical, Inc. filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.(jfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,993,520; US 11,207,372. (jfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: January 30, 2035. Thirty Month Stay Deadline: N/A (jfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Long Grove Pharmaceuticals, LLC (Filing fee $ 405, receipt number ADEDC-4290738.) - filed by Par Pharmaceutical, Inc., Par Sterile Products, LLC, Endo Par Innovation Company, LLC. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Civil Cover Sheet)(jfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
